In this study we targeted Olig2, a basic helix-loop-helix transcription factor that plays an important role in motoneuron and oligodendrocyte development, in human embryonic stem cell (hESC) line BG01 by homologous recombination. One allele of Consistent with previous reports on rodents, early GFP-expressing cells appeared biased to a neuronal fate whereas late GFP-expressing cells appeared biased to an oligodendrocytic fate. This was corroborated by myoblast coculture, transplantation into the rat spinal cords and whole genome expression profiling. The present work reports an hESC reporter line generated by homologous recombination targeting a neural lineage specific gene, which can be differentiated and sorted to obtain pure neural progenitor populations.
INTRODUCTION
Early developmental events have been difficult to study in humans and much of our understanding of neuron and glial cell differentiation has come from studies of mice and rats. Human embryonic stem cells (hESCs) [1] , capable of self-renewal and differentiating into cells of all three germ layers, are ideal to model human development and diseases, especially when combined with gene targeting technology [2] . Although homologous recombination has been achieved in hESCs for several genes including Oct4, Hprt1, Mixl1, the human Rosa locus, Fezf2 and several unspecified loci [3] [4] [5] [6] [7] [8] [9] [10] , the lack of hESC knockin reporters in the neural lineage prompted us to generate a neuroglial reporter line using gene targeting.
Olig2 is a basic helix loop helix (bHLH) transcription factor and an important fate regulator in neurogenesis and gliogenesis in the central nervous system (CNS) [11] [12] [13] [14] [15] [16] [17] . Double knockout of Olig2 and another Olig family member Olig1, results in ablation of oligodendrocytes and motoneurons in mice [12, 15] . Reporter genes knocked in at Olig loci in mice provided valuable lineage tracing data in vivo [12, 15, 18, 19] and in vitro [20, 21] .
In the present study, we have generated a cell line designated R-Olig2 in which an enhanced GFP (EGFP) cassette was inserted to the Olig2 locus of hESC line BG01 via homologous recombination. R-Olig2 remained pluripotent, had a normal karyotype, and allowed for direct visualization of Olig2 expression by fluorescence microscopy and purification of Olig2+ precursors by fluorescence-activated cell sorting (FACS). This work provides a powerful tool to study motoneuron and oligodendrocyte lineage development in human, which will also facilitate research on cell based therapy for the treatment of several neurological conditions, including spinal cord injury, multiple sclerosis and amyotrophic lateral sclerosis.
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MATERIALS AND METHODS
Construction of Olig2-EGFP knockin vector
A human BAC clone containing the Olig2 gene was purchased from Invitrogen (Clone No. RP11-585D4) and verified by PCR amplification of the Olig2 gene. The targeting vector was constructed in DH5α using red recombination as described [22] . The translational start codon of Olig2 was designated as the +1 position and was used throughout to describe the Olig2 gene. To generate the targeting construct, pStartK was used as the template to amplify the fragment outside attL1 and attL2. The primers contained two overhangs that were homologous to the flanking sequence of Olig2, so that when this PCR product was transformed into the ET competent Olig2 BAC, full-length Olig2 gene and ~2kb of its upstream and ~5.3kb of its downstream sequences were pulled out into pStartK as selected by kanamycin. The resultant plasmid was named pStartKhOlig2 and its sequence was verified by limited sequencing. Then, a fragment containing a total of 100 bp homology arm of Olig2 exon 2 (-19 to +30 and +976 to +1025, respectively), two AscI sites and cat, the gene encoding chloramphenicol was amplified and co-transfected with pStartK-hOlig2 into ET competent DH5α, seeking to replace the Olig2 exon 2 by cat, and the resultant plasmid was selected by chloramphenicol and ampicillin. The positive plasmid was verified by partial sequencing and named pStartKhOlig2cam. pStartK-hOlig2cam was then digested by AscI and an EGFP-neomycin fragment was purified and ligated into pStartK-hOlig2cam, resulting in pStartKhOlig2eGFP, in which cat was swapped with a sequence encoding EGFP and neomycin (expression of neomycin was driven by RNA Pol II promoter). In order to add a negative selection site to this vector, pStartK-hOlig2eGFP was incubated with a multisite gateway 
Generation of the Olig2-GFP knockin reporter line R-Olig2 from BG01
The BG01 hESC line (46, XY) was maintained as described [23] . Briefly, BG01 cells were cultured on a layer of mitomycin C (Sigma) inactivated mouse embryonic fibroblast cells (MEF) in hESC medium containing DMEM-F12, 20% knockout serum replacement, 1% non-essential amino acid, 55 µM 2-mercaptoethanol, 2 mM Lglutamine, supplemented with 4 ng/ml basic FGF (all above from Invitrogen). Cells were passaged using collagenase IV (1 mg/ml, Invitrogen) at a ratio of 1:2 to 4 every 4-5 days.
Routine karyotyping examination was done every 10 passages.
To generate the Olig2-GFP knockin reporter R-Olig2, a total of 5x10 6 
In vitro differentiation of R-Olig2
For random differentiation [23] , embryoid bodies (EBs) were generated by triturating R-Olig2 ES cells into small clumps and grown in hESC medium (without bFGF) in suspension for 4 days. EBs were then plated onto Geltrex (Invitrogen) coated dishes and continued to differentiate as adherent cultures for an additional 17 days before immunocytochemistry analysis for germ layer specific markers.
Differentiation of R-Olig2 into Olig2+/GFP+ cells
To induce GFP (Olig2) expression, R-Olig2 cells were maintained in hESC medium and detached using collagenase IV. Cells were triturated to make small clumps, which were then transferred to Ultralow attachment dishes (Corning) to form spheres.
Spheres were cultured in suspension for 5 days in MDFK5 medium [24, 25] (DMEM-F12 with glutamax, 5% knockout serum replacement, 1x N2, 1% Non-essential amino acid, 55 µM 2-mercaptoethanol, all from Invitrogen). Spheres were further induced to express Olig2-GFP by adding 10 µM all-trans-retinoic acid (Sigma) and 30 ng/ml recombinant sonic hedgehog (Shh, R&D systems) or 1 µM Shh agonist Purmorphamine [26] (CalBiochem) everyday. Spheres generated from these R-Olig2 cells were then examined under fluorescence microscopy for the expression of GFP and subsequent co-labeling of Olig2 by performing immunocytochemistry with an Olig2 antibody. At various time points of differentiation, spheres were harvested for flow cytometric analysis to evaluate the expression of GFP or were fixed with 2% paraformaldehyde and sectioned for direct visualization of GFP and immunocytochemistry of other markers.
To further induce differentiation along the motoneuron or oligodendrocyte lineage, GFP+ spheres were manually picked under fluorescence microscopy. For motoneuron differentiation, GFP+ spheres were seeded onto C2C12 myoblasts (ATCC) and cultured for an additional 5-10 days in MDFK5 medium supplemented with 1xB27, brain-derived neurotrophic factor (BDNF, 10 ng/ml), glial cell line derived neurotrophic factor (GDNF, 10 ng/ml), insulin like growth factor 1 (IGF1, 10 ng/ml), and retinoic acid (1 µM). For oligodendrocyte precursor and oligodendrocyte differentiation, GFP+ spheres were seeded onto fibronectin coated plates and induced in MDFK5 medium supplemented with platelet derived growth factor (PDGF-AA, 10 ng/ml), 3,3,5 triiodothyronine (T3, 30 ng/ml) and Purmorphamine (1 µM) for 5-10 days.
Purification of Olig2+/GFP+ cells by fluorescence activated cell sorting (FACS)
Purification of Olig2+/GFP+ cells was carried out as described previously [27] .
Briefly, differentiated R-Olig2 cells were harvested using 0.25% Trypsin and resuspended in 5% FBS in PBS at a density of 5x10 6 to 1x10 7 per milliliter. Cell purification was performed using a FACSstarPlus cell sorter (Becton Dickinson
Immunocytometry Systems) at 4°C at a rate of 2,500 cells/s. The positively sorted cells were re-examined by FACS and found to have a purity of 91%-95%.
Transplantation of GFP+ cells to adult rat spinal cords
Animal experiments were performed with the approval of the Johns Hopkins University IACUC. Sprague-Dawley rats were purchased from Taconic. Transplantation 
Immunocytochemistry
Immunocytochemistry and histology were performed as described [29, 30] .
Briefly, hESCs, EBs or tissue sections were fixed using 2% paraformaldehyde and incubated in blocking buffer (5% goat serum, 1% bovine serum albumin, and 0.1% Triton was used to identify the nuclei. Images were captured using a Zeiss Axiovision microscope with z-stack split view function. For z stacks, images were taken at 1 µm increments and processed using Axiovision software and AdobePhotoshop. Please note that all images involved GFP were captured directly under fluorescence or confocal microscope without immunostaining using a GFP antibody unless indicated otherwise.
Comparison of global gene expression of early and late GFP+ sorted cells by bead based cDNA microarray
Bead based Illumina microarray was performed as described previously [31] .
Briefly, RNA was isolated from undifferentiated R-Olig2 or GFP+ sorted cells using TRIzol (Invitrogen) and 100 ng total RNA was used for amplification and hybridization to Illumina HumanRef-8 BeadChip according to the Manufacturer's instructions (Illumina). Array raw data were processed using Illumina BeadStudio software. Gene expression levels were considered significant only when their detection p-value ≤0.01.
Comparison was made between GFP+ sorted cells of early (day 17 of differentiation) and late stage (day 38 of differentiation), and stage specific genes were identified.
RESULTS
Generation of the Olig2-GFP knockin hESC line R-Olig2
To generate the Olig2-GFP knockin reporter line R-Olig2, we transfected BG01
hESCs with targeting vector pWSTK3_hOlig2eGFP using electroporation ( Figure 1 ).
After successful homologous recombination, exon 2 of the Olig2 gene was replaced by EGFP. Among the 106 clones that have been selected through both positive (G418) and
have been identified to be correctly targeted in one allele while the other allele remained 
R-Olig2 cells are pluripotent
To further evaluate the basic hESC characteristics of R-Olig2, we examined pluripotency markers in R-Olig2 using BG01 as a wild type control. Identical to BG01, R-Olig2 cells were grown on a layer of inactivated MEF or in MEF conditioned medium and were passaged every 4-5 days at a ratio of 1:2 to 4. As shown in Supplementary 
Induction of GFP expression in R-Olig2 and purification of GFP+ cells by FACS
One major goal of this work was to generate a tool which could be used to purify Olig2+ precursors. We therefore differentiated R-Olig2 into Olig2+/GFP+ cells using 
Distinct gene expression profile for early and late GFP+ cells
To further characterize the early and late stage GFP+ cells, we harvested differentiated spheres at both early (day 17) and late (day 38) stages, and sorted for GFP+ cells ( Figure 5A , B) for gene expression analysis using Illumina bead array. As expected, Olig2 was highly expressed in both populations as compared to undifferentiated R-Olig2
ES cells ( Figure 5C , D, 6549 and 2120 folds, respectively). Early stage GFP+ sorted cells differentially expressed several Hox proteins, indicating the initiation of the caudalization process. Genes that are important in motoneuron specification and maturation were also highly expressed [36] , including HB9, Isl2, Mash1, GDF11, SCIP, and NeuroD ( Figure   5C ). By contrast, genes that are involved in the early commitment of glia and oligodendrocyte differentiation [37, 38] were upregulated in late stage sorted GFP+ cells, among them PTPU2, Dlx2, GLT-1 (EAAT2), GLAST (EAAT1), GDF10, THRA (thyroid hormone receptor α), and Nkx6.2. Some myelination associated genes such as MYT1L were also upregulated ( Figure 5D ).
GFP+ cells gave rise to oligodendrocytes in vivo after transplantation
To The targeting efficiency of Olig2 in BG01 was 5.7%, which is higher than those reported in hESCs by homologous recombination so far (Oct4: 3.9%; Hprt1: 2%, Fezf2:
1.5%, and the human Rosa locus: 2.3%) [3] [4] [5] [6] [7] [8] [9] . While the difference could be due to the accessibility of different genomic loci, we believe that the novel method we used to make the targeting construct directly from Olig2-containing human BAC clones played a critical role. Although a non-isogenic DNA vector was used [39] , this protocol was more efficient and precise than conventional methods, and provided more flexibility when designing the homology arms for desired genes or gene fragments. We noted that an efficiency of as high as 40% was reported for Oct4 targeting [6] , however, this targeting strategy of using endogenous Oct4 promoter to drive the positive selection cassette is only suitable for genes that are highly expressed in the undifferentiated ES cells, and cannot be adapted to lineage-specific genes.
We further found that floxing out the neo cassette in homologous recombinants is essential to ensure appropriate GFP expression. When compared between clones prior to and after the removal of neo cassette, we found that with the presence of neo cassette, GFP expression was very low and could not be used for direct detection by fluorescence microscopy or FACS purification. In mice, elegant systems have been designed to overcome this problem in vivo [40] . In cultured hESCs, a more efficient and preferably a "zero-footprint" system is worth developing although currently this can be done by transiently transfecting a Cre construct (Ref. [3, 4] and the current study) or a cell permeant Cre protein [41] .
A useful lineage hESC reporter line needs to meet the following criteria: (1) expression of the reporter recapitulates the targeted endogenous gene, and (2) the transgene does not disrupt or interfere with the function of the gene of interest or any other genes especially the essential genes in the genome. Several genetic engineering strategies have been used to make reporter lines for hESCs, including random integration, BAC transgenesis, and viral vectors [42] [43] [44] . These strategies while efficient, are random in nature when integrated to the genome, thus the possibility of bringing undesired effects at molecular or cellular level cannot be completely excluded. Moreover, often times the promoter fragments that drive reporter cassettes are not regulated in the same manner as the endogenous gene and a faithful replication of expression is difficult to achieve [45] . A more reliable and predictable strategy is gene targeting, as reported in this manuscript and by others [3] [4] [5] [6] [7] [8] [9] [10] (reviewed in [46, 47] Supplementary Figures 1-4) . Therefore missing one copy of Olig2 gene did not affect R-Olig2's function as an otherwise normal hESC line. GFP+ cells differentiated and purified from R-Olig2 showed predicted differentiation and gene expression profiles and should reflect the characteristics of the corresponding cell types derived from the non-engineered BG01.
Olig2 has been shown to have a transcription repressor function [11, 48, 49] and is a key gene in promoting oligodendrocyte and suppressing astrocyte differentiation [11-13, 15, 18, 19] . In mice, Olig2 interacted with several transcription factors, such as Ngn2, Zfp488 and NFIA/NFIB [11, 50, 51] . In humans, Olig2 is expressed in several types of malignant gliomas and is critical for maintaining proliferation of neural stem cells [17, 52] , yet detailed mechanism of the Olig2 function remains elusive. The present work provides a powerful tool to study the role of the Olig2 gene. Stage-dependent Olig2+ populations can be purified by GFP+ sorting, and GFP intensity is high enough to serve as a readout to screen for growth factors or small molecule compounds that promote or inhibit the expression of Olig2. Using R-Olig2 as a genetic engineering platform we can further discover key pathways and transcriptional regulatory networks for oligodendrocyte and/or motoneuron proliferation and differentiation in humans. In addition, R-Olig2 may also be valuable for cross species comparisons to elucidate evolutionarily conserved and divergent pathways regulating development and tissue repair [53, 54] .
Transplantation studies provide important clues for clinical trials of cell based therapy. However, silencing of randomly integrated ectopic genes after transplantation has been reported, which has inhibited the use of cell labels for in vivo tracking. We reasoned that such silencing would be less likely to occur in a homologous recombination targeted gene. As expected, after being transplanted into the rat spinal cord, GFP expression was maintained in R-Olig2 derived oligodendrocyte precursors and mature oligodendrocytes, and was readily visualized by fluorescence microscopy without the need of any enhancement (such as immunostaining), indicating that R-Olig2 can be reliably used for short-term lineage tracing experiments in vivo or in transplantation studies of animal disease models.
The pattern of GFP expression suggests that Olig2 is expressed in either two lineages or in a single lineage that changes its developmental potential. Only the early Olig2+ precursors have the ability to make motoneurons and we as yet do not know the fate of the very early Olig2-expressing cells. Our current data do not allow us to distinguish between them, we have however, provided a platform for future study of this topic.
CONCLUSION
We present a genetically engineered hESC reporter line generated by homologous Six clones were identified to be correctly targeted to the Olig2 locus by Southern blot using a 5' flanking probe. R-Olig2, the representative clone is shown with a 6.2 kb band of targeted allele and a 3.9kb band for the wild type allele, as predicted (B). Floxed neo cassette was further removed by transient transfection of a Cre construct (C) and displayed absence of genomic integration of Cre fragment by PCR (D). To examine GFP expression, R-Olig2 cells were induced by Shh agonist and retinoic acid for 16 days before differentiated spheres were fixed, sectioned and stained with Olig2 antibody (E). All cells that were labeled with Olig2 antibody co-expressed GFP (F, G), which was directly visualized under fluorescence microscope. Panel H shows higher magnification of the boxed area in G. Bar, 50 µm. 186x149mm (300 x 300 DPI) Figure 2 . GFP expression reflects endogenous Olig2 expression along the neural differentiation pathway. R-Olig2 cells were induced with Shh agonist and retinoic acid and the expression of transcription factors Olig2, Pax6 (A, D, G, J), HB9 (B, E, H, K) and Nkx2.2 (C, F, I, L) was examined by immunocytochemistry along with GFP expression (direct visualization under fluorescence microscope) at d10, d16, d22 and d26 of differentiation. Pax6 was first detected at d10 (red, A) and starting at d16, a subset of Pax6+ cells co-expressed Olig2 and GFP (arrowheads, D, G, J). Although Olig2 and GFP expression was detected as early as d10, almost no expression was detected for motoneuron marker HB9 (B), until d19 of differentiation (arrow, E), when the majority of cells did not co-express HB9 and Olig2. Some HB9+ cells co-expressed GFP but not Olig2 (arrowheads, E, H, K). Nkx2.2 did not co-label with Olig2 or GFP at the early stages of differentiation (arrow, C, F), and the initiation of co-expression of Nkx2.2 and Olig2 and GFP could be observed starting from d22 (arrowheads, I, L). Insets show higher magnification images of boxed areas in corresponding panels. Detailed time course images are shown in Supplementary  Figures 2-4 . Bar, 50 µm. 202x212mm (300 x 300 DPI) Figure 3 . Early GFP-expressing cells are likely motoneuron precursors which have the ability to make synapses. Twenty-one-day differentiated GFP+ spheres were harvested and co-cultured with C2C12 myoblasts for 5-10 days. GFP+ cells were able to cause acetylcholine receptor aggregation, as detected by staining using an antibody against α-BTX (arrows, panels A and D, B and E, and C and D show aggregations of three representative fields at the neuromuscular junction). Although cell bodies of the motoneurons were still weakly visible under green fluorescence microscopy, GFP expression in most neuron processes was downregulated as cells matured. Antibodies of GFP (A-C) and βIII tubulin (blue, D-F) were used to delineate the cell bodies and processes of these GFP+ cellderived motoneurons. Images of z stacks were taken at 1 µm increments and A'-F' and A''-F'' are xz and yz views processed by Zeiss Axiovision software. GFP Ab: GFP antibody. Bar, 25 µm. 129x116mm (300 x 300 DPI) In the heatmaps, high expression levels relative to mean values (average signals of ES, d17 and d38 of the corresponding genes) are colored red. Low expression levels are colored green. Black represents no significant change in the expression level between mean and sample. Fold increase of gene expression level of d17 and d38 GFP+ cells compared to undifferentiated R-Olig2 ES cells is listed in the tables in C and D. 174x132mm (300 x 300 DPI) Figure 6 . Engrafted late stage GFP+ cells migrated and differentiated into oligodendrocyte progenitors and oligodendrocytes after transplantation into the rat spinal cords. Engrafted GFP+ cells survived, migrated and integrated into the host white matter regions of the cervical spinal cord robustly as identified by GFP (A) and an antibody against human nuclear antigen (hNA) (arrows, R-U). Specifically, at 2 weeks posttransplantation, engrafted cells co-expressed GFP and oligodendrocyte precursor markers PDGFRα (arrow, B-E) and NG2 (arrow, F-I). By 6 weeks posttransplantation, cells continued to express GFP, migrated further from the injection site (*, A) and started to myelinate the host tissue, as evidenced by co-expression of GFP and PLP (arrow, J-M"), and GFP and CNP (arrow, N-Q"). Some transplanted cells differentiated into astrocytes as detected by GFAP staining (V, inset shows higher magnification of the boxed area). For panels J-Q", z stack images were taken at 1 µm increments. M' and Q' and M''-Q'' are images of xz and yz views processed by Zeiss Axiovision software. GFP was directly visualized under fluorescence microscopy. Residual GFP expression could be observed when cells differentiated into GFAP+ astrocytes. When late stage GFP+ cells were differentiated into GFAP+ astrocytes, a small subpopulation of GFAP+ cells still expressed GFP, which were visualized directly by fluorescence microscopy (arrow). Bar, 50 µm. 66x54mm (300 x 300 DPI)
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